Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines
Completed
Montefiore Medical Center
Phase 3
2005-07-01
Migraines are a specific type of headache that frequently recur and are very painful.
Although there are many medications that are effective against migraines, none of these
medications cure 100% of migraines. Another problem with migraines is that although many
times they get better after intravenous (IV) treatment in the emergency room (ER), about 1/3
of the time migraines recur the next day. The purpose of this research project is to see if
adding a medication called dexamethasone to standard ER therapy will help patients get better
quicker and stay pain-free more often than if they receive placebo.
A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach
Completed
Johnson & Johnson Consumer and Personal Products Worldwide
Phase 4
1969-12-31
The purpose of this study is to compare several analgesics given in approved daily doses in
combination with a daily cardioprotective dose of aspirin (81 mg), to study their bleeding
properties and their effects on the stomach in healthy volunteers.
The purpose of this study is to test the hypothesis that Fragmin (dalteparin sodium)
subcutaneously once daily for 7 days is more effective than Ibuprofen given orally three
times daily for 7 days for the treatment of superficial thrombophlebitis (STP).
The purpose of this study is to test the hypothesis that Fragmin (dalteparin sodium)
subcutaneously once daily for 7 days is more effective than Ibuprofen given orally three
times daily for 7 days for the treatment of superficial thrombophlebitis (STP).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
